US Surgeon General will speak at 2010 BIO convention.April 13, 2010 -
US Surgeon General Dr. Regina Benjamin will deliver keynote address at May 3 summit during 2010 BIO International Convention, held May 3-6 in Chicago. Summit will focus on importance of integrating diverse and underserved populations within medical, agricultural, and energy research industry; increasing employment opportunities; and encouraging clinical trial participation. Following keynote, 2 breakout sessions will address diversity in workplace and its role in therapy development.
U.S. Surgeon General to Speak at 2010 BIO International Convention |
(Archive News Story - Products mentioned in this Archive News Story may or may not be available from the manufacturer.)
Biotechnology Industry Organization
1201 Maryland Ave., SW, Ste. 900
Washington, DC, 20024
USA
Press release date: March 18, 2010
Dr. Benjamin to Keynote Diversity in Biotechnology Summit
WASHINGTON, D.C. - U.S. Surgeon General Dr. Regina Benjamin will deliver the keynote address at the May 3 summit which will take place during the 2010 BIO International Convention being held May 3-6 in Chicago. The summit will focus on the importance of integrating diverse and underserved populations within the medical, agricultural and energy research industry, increasing employment opportunities and encouraging participation in clinical trials. The Surgeon General's keynote address will begin at noon.
"I have long admired Dr. Benjamin's service and her dedication to preventative care and outreach to underserved communities. I look forward to her speech on the potential of strategic partnerships to accelerate new developments in biotechnology particularly in the therapeutic sectors, ultimately benefitting an increasingly diverse population," said BIO President and CEO Jim Greenwood.
Following the keynote will be two breakout sessions which address diversity in the workplace and the role of diversity in the development of new therapies, "Implementing Advocacy and Best Practices: Why It's Essential to Your Business," and "The Broader Impact of Evidence Based Research on Access and Innovation." The event will conclude with a networking reception.
Other confirmed speakers at the Diversity Summit include experts representing academia, health and other professionals and major corporations:
Melissa Harper, Director of Global Talent Acquisition/Corporate Diversity for Monsanto
Zelema Harris, Chancellor of St. Louis Community Colleges
Jean Mossman, European Federation of Neurological Associations
Armin Weinberg, Director of the Chronic Disease Prevention and Control Research Center at Baylor College of Medicine
The Diversity in Biotechnology Summit will be held at the Hyatt Regency McCormick Place from noon - 5:00 p.m. and is free and open to all attendees and members of the community.
For more information on the 2010 Diversity in Biotechnology Summit, please visit http://convention.bio.org/diversity/.
The BIO International Convention helps to support the association's programs and initiatives. BIO works throughout the year to create a policy environment that enables the industry to continue to fulfill its vision of bettering the world through biotechnology innovation. For more information on the global event for biotechnology, including program, registration, and housing information, please visit http://convention.bio.org/
Upcoming BIO Events
BIO Intellectual Property Counsels Spring Conference and Committee Meeting April 19-21, 2010 New Orleans, LA
Partnering for Global Health May 3, 2010 Chicago, IL McCormick Place Convention Center
BIO International Convention May 3-6, 2010 Chicago, IL McCormick Place Convention Center
2010 BIO Human Resources Conference May 4-7, 2010 Chicago, IL
World Congress on Industrial Biotechnology and Bioprocessing June 27-30, 2010 Washington, DC
BIO India September 21 - 22, 2010 Hyderabad, India
BIO's Livestock Biotechnology Summit September 28-30, 2010, Sioux Falls, SD
About BIO
BIO represents more than 1,200 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world's largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world.
|
|
|
|
|
|
